Public M&A: JV’s with exclusivity under SEBI’s scanner – The Linde Case

Public M&A: Do List Cos Really Need Omnibus RPT Approvals?

SEBI’s Proposed Disclosure Regime: Impact on Public M&A and Directors’ Liabilities

Unexplored Strategies in the Fortis Saga: Public shareholders and IHH Healthcare exposed to significant collateral damage?

Decoding Boardroom Dilemmas (Part III): Can Nominee Directors Share UPSI with Nominating Shareholders?

Decoding Boardroom Dilemmas – Hiving Off to Fundraise Through Subsidiaries – Commercial Wisdom or Short-Changing Public Shareholders?

Should Offshore Funds Appoint Directors?

Threat of valuation litigation in Public M&A – Carlyle-PNB Effect!